相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Indirect Sympatholytic Actions at β-Adrenoceptors Account for the Ocular Hypotensive Actions of Cannabinoid Receptor Agonists
Brian D. Hudson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
Douglas McHugh et al.
BMC NEUROSCIENCE (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
R. G. Pertwee
CURRENT MEDICINAL CHEMISTRY (2010)
Architecture of Cannabinoid Signaling in Mouse Retina
Sherry Shu-Jung Hu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2010)
The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways
Heather B. Bradshaw et al.
BMC BIOCHEMISTRY (2009)
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
Lina M. Lauffer et al.
DIABETES (2009)
Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation
Jesica R. Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano et al.
PHYSIOLOGICAL REVIEWS (2009)
Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92
Da Young Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Neuroprotective and Intraocular pressure-lowering effects of (-)Delta 9-tetrahydrocannabinol in a rat model of glaucoma
James Crandall et al.
OPHTHALMIC RESEARCH (2007)
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18
Masashi Kohno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators
Heather B. Bradshaw et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas
Matthew J. Gastinger et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Finding of endocannabinoids in human eye tissues: implications for glaucoma
J Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase
K Tsuboi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander
A Straiker et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain
SM Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein
A Porcella et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
